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Introduction
Proliferation of putative hepatic stem cells has been observed in both experimental animal models of liver injury and human pathologic ductular reactions (1) (2) (3) (4) . Small hepatocyte-like oval cells originated from ductules in response to various toxic or carcinogenic agents appear to represent a progeny of the facultative hepatic stem (oval) cell compartment (5) (6) (7) . A mouse model of chronic liver disease induced by feeding of mice with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) has attracted particular attention (8, 9) . The most intriguing characteristics of the liver from these mice have been the appearance and progressive accumulation of small oval cells with a positive staining for A6 antigen, a marker of proliferating ductular epithelial cells (10) .
The roles for peptide growth factors, such as transforming growth factor-α (TGF-α ), in hepatic stem cell proliferation and differentiation have been studied (11, 12) . In contrast, the biological significance of unique phospholipid growth factors such as lysophosphatidic acid (LPA) in stem cell biology, is largely unknown. The cellular effects of LPA are mediated predominantly via G-protein coupled receptor subfamily encoded by endothelial differentiation genes (EDG) (13) (14) (15) (16) ). There are three major receptor subtypes, which preferentially bind LPA : LPA1 (former EDG2), LPA2 (EDG4) and LPA3 (EDG7) (16). LPA induces proliferation of hepatic stellate cells (HSC) (17, 18) , and increases motility and migration of human hepatoma cell line (19) .
In contrast, growth inhibition by LPA was reported in primary rat hepatocytes (20) . Our recent studies revealed the presence of LPA1 and LPA2 receptors in the proliferating AML12 murine hepatocyte cell line, which overexpress TGF-α (21, 22) . In these hepatocytes, LPA protected the cells from apoptosis induced by TNF/D-galactosamine or Clostridium difficile exotoxin exposure. Herein we report the expression of LPA receptors and their co-localization with A6 antigen in the injured murine liver. Moreover, we found co-expression of the hepatic LPA1 4 receptor and the SCA-1 antigen, a hematopoetic stem cell marker. These data demonstrate for the first time that the induction of the receptors for LPA may be a necessary part of mechanism responsible for activation of hepatic stem cells in regenerating liver, thereby implicating LPA as an important growth factor involved in the recovery from hepatic injury.
Materials and Methods.

Materials.
DDC ( SCA-1 monoclonal antibody were purchased from Pharmingen (San Diego, CA). Radiolabeled Induction of oval cell proliferation in vivo. Induction of mouse chronic liver injury accompanied by oval cell proliferation was performed using the procedure described by Preisegger et al. (10) . Mice (5-week-old, C57BL/6J) were given the standard grain-based diet (NIH-31) containing 0.1 % DDC (BioServ, Inc. Frenchtown, NJ) and allowed food and water ad libitum. Five weeks after initiation of the diet, mice were sacrificed, and livers were processed as described below.
Western blot analysis of EDG receptors.
For Western blot analyses of EDG receptors, liver specimens were excised, thoroughly rinsed with cold PBS and homogenized on ice in Western blot buffer as described previously in detail (21) . Samples (50 g protein) were subjected to SDS-PAGE (12% gel), and electroblotted onto polyvinylidene difluoride membranes. Membranes were blocked in 10 mM tris (pH 7.5), 100 mM NaCl, 0.1% Tween-20 containing 5% nonfat dry milk for 60 min at room temperature. After overnight incubation with primary antibodies (1 g/ml, 4 o C), proteins were visualized using a goat anti-rabbit antibody conjugated to HRP and a chemiluminescense detection system. 
Immunohistochemistry
Results
Induction of hepatic expression of EDG receptors for LPA in chronic liver injury.
Expression of LPA1, LPA2 and LPA3 receptor proteins in the liver was first characterized by western blot analyses. All these proteins have a molecular weight (MW) of 41-43 kDa calculated from the deduced amino acid sequence. The LPA1, but not LPA2 or LPA3
antibody revealed immunopositive proteins with the relevant MW in normal mouse liver (Fig. 1) .
Hence, western blot analysis showed that the levels of the LPA receptor protein in intact control liver are either very low (LPA1) or not detectable (LPA2 and LPA3). Feeding of mice with DDC for five weeks resulted in the dramatic increase in the expression of the LPA1, and induction of expression of LPA2 and LPA3 proteins (Fig 1) .
Immunohistochemistry of hepatic EDG receptors for LPA.
A routine histological analysis of liver tissue revealed the proliferation of interlobular bile ducts, which formed wide lumens. The expected features of marked cholestasis with bile deposits in bile ducts and ductules, portal tract fibrosis, and inflammatory infiltration, were observed in the livers of DDC-treated mice.
In normal mouse liver, the LPA1 receptor protein was barely detectable, and probably restricted to non-parenchymal cells with the occasional immunopositive staining in ductular epithelium (Fig. 2 a) . No LPA1-positive immunoreactivity was found in hepatocytes. In DDCinduced liver damage, the LPA1 receptor was expressed in small cells, which were located in the vicinity of the portal tracts, and which spread into parenchyma and formed clusters ( Fig. 2 b, see inset). In contrast to LPA1, the LPA2 and LPA3 receptor proteins were essentially not detectable in normal liver by immunohistochemistry (Fig. 2 c, e) ; only a very rare LPA2-positive ductular staining was observed (Fig. 2 c) . DDC treatment resulted in the appearance of periportal LPA2 positive small cell collectives similar to, but to a lesser extent than LPA1 reaction (Fig. 2 d) . No LPA3 receptor immunoreactivity was found in normal liver (Fig. 2 e) , while in DDC-treated mice, LPA3 receptor protein was expressed and localized predominantly in ductular epithelium (Fig. 2 f) .
Hepatic LPA1 and LPA2 receptors are co-localized with the A6 antigen, and co-expressed with the SCA1 antigen in DDC-treated mice.
No positive A6 staining was found in the liver tissue of control mice, and in the liver samples from DDC-treated mice incubated without primary A6 antibody (data not shown). Mice maintained on DDC-containing diet exhibited very high levels of A6 antigen-positive staining in the liver, including bile duct and ductular epithelum cells (Fig. 3 a, arrow) . Remarkably, DDC diet induced the proliferation of A6 positive small oval cells in the periphery of portal tracts, and extensive accumulation of these cells in the hepatic parenchyma (Fig. 3 a, arrowhead) . The cells harboring A6 antigen formed clusters in the liver parenchyma in the surrounding area of portal tracts.
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The LPA1 and LPA2 receptors were co-localized with the A6 antigen on the serial sections of liver tissue. There was focal coincidence of A6 and LPA1 immunoreactivity in the periportal small cell clusters, bile duct epithelium and bile ductular epithelium (Fig. 3 b) . LPA2 receptor immunoreactivity was identified primarily in bile duct epithelial cells (Fig.3 c) . In DDC-treated levers, stem cell antigen SCA-1 was also expressed intensely and was found to reside in duct and ductular epithelium, and to a lesser extent, in small cells in the parenchyma nearby portal tracts (Fig. 4 a) . LPA1 receptors were coexpressed with the SCA-1 antigen in similar locations as indicated on the serial liver sections (Fig. 4 b), suggesting the possible association of LPA1 with bone marrow-derived hepatic stem cells during liver regeneration.
Hepatic levels of LPA.
Lipids were extracted from liver specimens of mice fed with DDCcontaining diet for five weeks and normal animals (control diet). LPA levels were significantly higher in DDC-treated mice: 679.0 + 41.2 pmol/g of liver weight, compared to control mice: 428.9 + 29.7
pmol/g of liver weight (Fig. 5) . The LPA levels in murine plasma were shown to be 170 ± 50 pmol/ml (23) . Thus, it appears that even in normal mice, hepatic levels of endogenous LPA may be slightly higher than in plasma.
Discussion
The novel and most important findings of these studies are: (i) induction of LPA1, LPA2
and LPA3 receptors ( Fig. 1 and 2 ) in mouse model of liver injury, which is accompanied by ductular proliferation, and (ii) co-localization of LPA1 receptors and A6 antigen; both are expressed in proliferating ductules and small cells, likely originated from ductular epithelium (Fig. 3) . LPA1 receptors were also co-expressed with the stem cell antigen SCA-1 (Fig. 4) . shown to co-express with SCA-1 antigens (Fig. 4) , marker of hematopoietic stem cells (25) . In addition, expression of SCA-1 antigen was obsereved in fetal liver (26) . Taken together, these data support our notion that EDG receptor expression may be associated with activation and proliferation of hepatic oval cells.
Little is known about the roles for LPA and its receptors in the liver. However, several findings in other systems propose such a role by comparison. For example, in developing brain, the LPA1 receptor is abundantly expressed at sites of neurogenesis, namely in the ventricular zone of cerebral cortex. The LPA1 expression was restricted to the timeframe of neuroblasts differentiation into mature neurons (27) . Similarly, Schwann cells expressed the LPA1 only within a limited period of differentiation from the precursor to myelinated cells (28 (Fig. 4 a) .
Magnification x400. LPA was extracted from liver tissues using n-butanol. Typically, ~0.5 g of the liver was homogenized in 3.0 ml of n-butanol. LPA was assayed in lipid extract and calculated as described in detail under Materials and Methods. Data are expressed as pmole of LPA per gram of crude liver. Nonpaired t-test was employed for the statistical analysis.
